Qualifications

 

 

  • American Society of Genitourinary Oncology Certification,  American Urological Association

  • Fellow of Royal Australasian College of Surgeons, (FRACS Urology) 

  • Doctor of Medicine (M.D. Thesis), University of Auckland

  • Bachelor of Medicine and Bachelor of Surgery (MBChB) University of Otago

 

Professional Memberships

 

  • Society of Urologic Oncology, Associate Member

  • Urological Society of Australia and New Zealand

  • Royal Australasian College of Surgeon

  • American Urological Association

  • European urology Association

 

Book Chapters

  • Zargar-Shoshtari K, Kovitz, C., Spiess, P., Tannir, N. Testicular Germ Cell Tumors,  Encyclopedia of Cancer (4th edition), Schwab, Manfred (Ed.) Springer Publications, 2016, ISBN 978-3-662-47424-2

  • Zargar-Shoshtari K, Sharma P, Spiess PE. Primary Urethral Carcinoma, Rare Urological Malignancies, (Editor: L. Pagliaro) Springer International Publishing Switzerland. 2016, (pp153-161), ISBN 978-3-319-30046-7

  • Sharma P, Zargar-Shoshtari K, Pow-Sang JM. Ilioinguinal Lymphadenectomy. In: Hinman’s Atlas of Urologic Surgery, 4th Ed (Editors: Dr. Joseph A. Smith, Jr. Stuart S. Howards, Glenn M. Preminger, and Roger R. Dmochowski) (In Press– January 2016).

  • Sharma P, Zargar-Shoshtari K, Zargar H, Spiess PE. Pelvic Lymph Node Dissection for Penile Cancer: Answering the Conundrum of When and How It Should Be Conducted. In ­­­­­Penile Cancer 2017 (pp. 81-92). Springer New York.

 

Journal Articles 

 

1.     Matti B, Zargar-Shoshtari K. Prostate cancer outcomes disparities: Population survival analysis in an ethnically diverse nation. In Urologic Oncology: Seminars and Original Investigations 2021 Apr 12. Elsevier.

2.     Matti B, Zargar‐Shoshtari K. Age‐adjusted reference values for prostate‐specific antigen in a multi‐ethnic population. International Journal of Urology. 2021 May;28(5):578-83.

3.     Mohammadrahim Kazemzadeh, Colin L. Hisey, Anastasiia Artuyants, Cherie Blenkiron, Lawrence W. Chamley, Kamran Zargar-Shoshtari, Weiliang Xu, and Neil G. R. Broderick, "Space curvature-inspired nanoplasmonic sensor for breast cancer extracellular vesicle fingerprinting and machine learning classification," Biomed. Opt. Express 12, 3965-3981 (2021)

4.     Mark S, Rashid P, Heathcote P, Zargar Shoshtari K. Differences in treatment choices for localised prostate cancer diagnosed in private and public health services. Med J Aust. 2021 Jun;214(10):485-485.e1. doi: 10.5694/mja2.51081. Epub 2021 May 11. PMID: 33977532.

5.     Matti B, Zargar-Shoshtari K. Prostate cancer screening in New Zealand: lessons from the past to shape the future in the light of changing evidence. N Z Med J. 2020 Oct 9;133(1523):87-95. PMID: 33032306.

6.     Matti B, Lyndon M, Zargar‐Shoshtari K. Ethnic and Socioeconomic disparities in Prostate Cancer Screening–Lessons from New Zealand. BJU international. 2020 Jun 29.

7.     Mir MC, Marchioni M, Zargar H, Zargar-Shoshtari K, Fairey AS, Mertens LS, Dinney CP, Krabbe LM, Cookson MS, Jacobsen NE, Griffin J. Nomogram Predicting Bladder Cancer–specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium. European Urology Focus. 2020 Aug 6.

8.     D'Andrea D, Black PC, Zargar H, Zargar-Shoshtari K, Zehetmayer S, Fairey AS, Mertens LS, Dinney CP, Mir MC, Krabbe LM, Cookson MS. Impact of sex on response to neoadjuvant chemotherapy in patients with bladder cancer. In Urologic Oncology: Seminars and Original Investigations 2020 Feb 11. Elsevier.

9.     Matthews SJ, Tyson M, Lauti M, Zargar K. Sexually transmitted infective vasitis mimicking left inguinal hernia: computed tomography clarifies diagnosis. ANZ journal of surgery. 2020 May 5.

10.  Matti B, Zargar-Shoshtari K. Opportunistic prostate cancer screening: A population-based analysis. In Urologic Oncology: Seminars and Original Investigations 2020 Jan 14. Elsevier.

11.  Kazemzadeh M, Broderick N, Xu W, Zargar-Shoshtari K. Design and optimization of broadband and transparent SERS based on transformation optics. In SPIE Micro+ Nano Materials, Devices, and Applications 2019 2019 Dec 31 (Vol. 11201, p. 112011L). International Society for Optics and Photonics.

12.  Black AJ, Zargar H, Zargar-Shoshtari K, Fairey AS, Mertens LS, Dinney CP, et al. The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy. Urologic Oncology-Seminars and Original Investigations. 2020;38(1).

13.  Rudzinski JK, Carlock HR, Beech BB, Zargar-Shoshtari K, Sharma P, Kim T, et al. Empty hemiscrotum and a giant abdominal mass case report. AME Medical Journal. 2019;4.

14.  Ong WM, Zargar-Shoshtari K, Siva S, Zargar H. Prostate specific membrane antigen: the role in salvage lymph node dissection and radio-ligand therapy. Minerva urologica e nefrologica,  The Italian journal of urology and nephrology. 2018 Oct;70(5):450-61.

15.  Bajaj M, Yuan, L, Holmes LC, Rice, M, Zargar-Shoshtari K, Predictors of Surgical Intervention Following Initial Surveillance for Acute Ureteric Colic, World Journal of Urology, 2018 Mar 29:1-7.

16.  Zargar-Shoshtari K, Sexton WJ Re: Stenting Prior to Cystectomy is an Independent Risk Factor for Upper Urinary Tract Recurrence, J Urol. 2018 May 14

17.  Ottenhof SR, Leone A, Djajadiningrat RS, Azizi M, Zargar-Shoshtari K, Kidd LC, Diorio G, Mosiello G, Graafland NM, Spiess PE, Horenblas S. Surgical and Oncological Outcomes in Patients After Vascularised Flap Reconstruction for Locoregionally Advanced Penile Cancer. European Urology Focus. 2018 Feb 9.

18.  Zargar H, Shah JB, Van Rhijn BW, Daneshmand S, Bivalacqua TJ, Spiess PE, Black PC, Kassouf W. Neoadjuvant dose dense MVAC versus gemcitabine and cisplatin in patients with cT3-4aN0M0 bladder cancer treated with radical cystectomy. The Journal of urology. 2018 Jun;199(6):1452-8.

19.  Zargar-Shoshtari K, Sharma P, Spiess PE. Insight into novel biomarkers in penile cancer: Redefining the present and future treatment paradigm?. Urologic Oncology: Seminars and Original Investigations 2017 Nov 2

20.  Chipollini J, Abel EJ, Peyton CC, Boulware DC, Karam JA, Margulis V, Master VA, Zargar-Shoshtari K, Matin SF, Sexton WJ, Raman JD. Pathologic Predictors of Survival During Lymph Node Dissection for Metastatic Renal-Cell Carcinoma: Results From a Multicenter Collaboration. Clinical genitourinary cancer. 2017 Oct 17.

21.  Zargar H, Shah JB, van de Putte EE, Potvin KR, Zargar-Shoshtari K, van Rhijn BW, Daneshmand S, Holzbeierlein JM, Spiess PE, Winquist E, Horenblas S. Dose dense MVAC prior to radical cystectomy: a real-world experience. World Journal of Urology. 2017 Apr 1:1-8.

22.  Nair R, Zargar-Shoshtari K, Zargar H. Bridging the gap: use of scaffolding tissue bio-grafts to bolster vesicourethral anastomosis during salvage robot-assisted prostatectomy reduced leak rates and catheter times. Translational Andrology and Urology. 2017 May 24.

23.  Zargar‐Shoshtari K, Hill AG. Surgical research in the public hospital. ANZ Journal of Surgery. 2017 Jun 1;87(6):428-9.

24.  Abel EJ, Spiess PE, Margulis V, Master VA, Mann M, Zargar-Shoshtari K, Borregales LD, Sexton WJ, Patil D, Matin SF, Wood CG. Cytoreductive Nephrectomy for Renal Cell Carcinoma Patients with Venous Tumor Thrombus. The Journal of Urology. 2017 Mar 6.

25.  Leone AR, Zargar-Shoshtari K, Diorio GJ, Sharma P, Boulware D, Gilbert SM, Powsang JM, Zhang J, Sexton WJ, Spiess PE, Poch MA. Neoadjuvant Chemotherapy in Elderly Patients with Bladder Cancer: Oncologic Outcomes from a Single Institution Experience. Clinical Genitourinary Cancer. 2017 Feb 1.

26.  Leone AR, Kidd LC, Diorio GJ, Zargar-Shoshtari K, Sharma P, Sexton WJ, Spiess PE. Bilateral benign renal oncocytomas and the role of renal biopsy: single institution review. BMC Urology. 2017 Jan 12;17(1):6.

27.  Zargar-Shoshtari K, Lawrentschuk N, Zargar H. Robotic Prostatectomy Delivers on the Promise of Minimally Invasive Surgery. Urology. 2016 Oct 6.

28.  Zargar-Shoshtari K, Murphy D, Zargar H, Word of Wisdom, Robotic versus open radical prostatectomy, Eur Urol. Sep. 2016 

29.  Sharma P, Zargar-Shoshtari K, Poch MA, Pow-Sang JM, Sexton WJ, Spiess PE, Gilbert SM. Surgical control and margin status after robotic and open cystectomy in high-risk cases: Caution or equivalence?. World Journal of Urology. 2016:1-7.

30.  Sharma P, Zargar-Shoshtari K, Pettaway CA, Schabath MB, Giuliano AR, Spiess PE. Disparities in Penile Cancer. Cancer Control. 2016 Oct;23(4):409-414.

31.  Zargar-Shoshtari K, Sexton WJ and. Poch MA, Management of urethral recurrences: Urothelial and Non-urothelial. Urologic Clinics of North America (Accepted for publication March 2016) 

32.  Leone A, Diorio G, Zargar-Shoshtari K, Spiess PE. Comprehensive characterization of the perioperative morbidity of cytoreductive nephrectomy. Transl Androl Urol. 2016 Jun;5(3):393-5.

33.  Zargar-Shoshtari K, Zargar H, Lotan Y, Shah JB, van Rhijn BW, Daneshmand S, et al. A Multi-Institutional Analysis of Outcomes of Patients with Clinically Node Positive Urothelial Bladder Cancer Treated with Induction Chemotherapy and Radical Cystectomy. J Urol. 2016;195(1):53-9.

34.  Zargar-Shoshtari K, Zargar H, Dinney CP, Ercole CE, Sharma P, Kovac E, et al. Clinical and therapeutic factors associated with adverse pathological outcomes in clinically node-negative patients treated with neoadjuvant cisplatin-based chemotherapy and radical cystectomy. World J Urol. 2016;34(5):695-701.

35.  Zargar-Shoshtari K, Sverrisson EF, Sharma P, Gupta S, Poch MA, Pow-Sang JM, et al. Clinical Outcomes After Neoadjuvant Chemotherapy and Radical Cystectomy in the Presence of Urothelial Carcinoma of the Bladder With Squamous or Glandular Differentiation. Clin Genitourin Cancer. 2016;14(1):82-8.

36.  Zargar-Shoshtari K, Sharma P, Djajadiningrat R, Catanzaro M, Ye DW, Zhu Y, et al. Extent of pelvic lymph node dissection in penile cancer may impact survival. World J Urol. 2016;34(3):353-9.

37.  Zargar-Shoshtari K, Kongnyuy M, Sharma P, Fishman MN, Gilbert SM, Poch MA, et al. Clinical role of additional adjuvant chemotherapy in patients with locally advanced urothelial carcinoma following neoadjuvant chemotherapy and cystectomy. World J Urol. 2016.  [Epub ahead of print]

38.  Zargar-Shoshtari K, Ashouri K, Sharma P, Baumgarten A, Sexton WJ, Pow-Sang J, et al. Nephrectomy and inferior vena cava thrombectomy for renal cell carcinoma among patients with impaired renal function: defining predictors of outcomes. ANZ J Surg. 2016;86(1-2):44-8.

39.  Zargar H, Zargar-Shoshtari K, Dundee P, Black PC. Predicting occult lymph node positive disease at the time of radical cystectomy: a systematic review. Minerva Urol Nefrol. 2016.

40.  Zargar H, Atwell TD, Cadeddu JA, de la Rosette JJ, Janetschek G, Kaouk JH, et al. Cryoablation for Small Renal Masses: Selection Criteria, Complications, and Functional and Oncologic Results. Eur Urol. 2016;69(1):116-28.

41.  Sharma P, Zargar-Shoshtari K, Spiess PE, Sexton WJ, Poch MA. Undiagnosed prostatic malignancy at the time of radical cystoprostatectomy after prior prostatic radiation therapy. Urol Ann. 2016;8(2):151-6.

42.  Sharma P, McCormick BZ, Zargar-Shoshtari K, Sexton WJ. Is surgeon intuition equivalent to models of operative complexity in determining the surgical approach for nephron sparing surgery? Indian J Urol. 2016;32(2):124-31.

43.  Sharma P, Henriksen CH, Zargar-Shoshtari K, Xin R, Poch MA, Pow-Sang JM, et al. Preoperative Patient Reported Mental Health is Associated with High Grade Complications after Radical Cystectomy. J Urol. 2016;195(1):47-52.

44.  Sharma P, Ashouri K, Zargar-Shoshtari K, Luchey AM, Spiess PE. Racial and economic disparities in the treatment of penile squamous cell carcinoma: Results from the National Cancer Database. Urol Oncol. 2016;34(3):122 e9- e15.

45.  Sammour T, Singh PP, Zargar-Shoshtari K, Su'a B, Hill AG. Peritoneal Cytokine Levels Can Predict Anastomotic Leak on the First Postoperative Day. Dis Colon Rectum. 2016;59(6):551-6.

46.  Acland G, Zargar-Shoshtari K, Rice M. Contemporary trends in urinary tract stone surgery, a regional perspective: Auckland, New Zealand. ANZ J Surg. 2016;86(4):244-8.

47.  Zargar-Shoshtari K, Spiess PE, Berglund AE, Sharma P, Powsang JM, Giuliano A, et al. Clinical Significance of p53 and p16 Status in a Contemporary North American Penile Carcinoma Cohort. Clin Genitourin Cancer. 2015.

48.  Zargar-Shoshtari K, Sharma P, Zargar H. Re: Medical Expulsive Therapy in Adults with Ureteric Colic: A Multicentre, Randomised, Placebo-controlled Trial. Eur Urol. 2015;68(5):910-1.

49.  Zargar-Shoshtari K, Sharma P, Spiess PE. Re: Oliver W. Hakenberg, Eva M. Comperat, Suks Minhas, Andrea Necchi, Chris Protzel, Nick Watkin. EAU Guidelines on Penile Cancer: 2014 Update. Eur Urol 2015;67:142-50. Eur Urol. 2015;67(6):e109-10.

50.  Zargar-Shoshtari K, Sharma P, Pow-Sang J. Salvage Therapies for Radiorecurrent Prostate Cancer. Urology Practice. 2015;2(3):126-32.

51.  Zargar-Shoshtari K, Sharma P, Espiritu P, Kurian T, Pow-Sang JM, Mangar D, et al. Caval tumor thrombus volume influences outcomes in renal cell carcinoma with venous extension. Urol Oncol. 2015;33(3):112 e23-9.

52.  Zargar-Shoshtari K, Kim T, Simon R, Lin HY, Yue B, Sharma P, et al. Surveillance Following Nephron-Sparing Surgery: An Assessment of Recurrence Patterns and Surveillance Costs. Urology. 2015;86(2):321-6.

53.  Zargar-Shoshtari K, Djajadiningrat R, Sharma P, Catanzaro M, Zhu Y, Nicolai N, et al. Establishing Criteria for Bilateral Pelvic Lymph Node Dissection in the Management of Penile Cancer: Lessons Learned from an International Multicenter Collaboration. J Urol. 2015;194(3):696-701.

54.  Zargar-Shoshtari K, Anderson W, Rice M. Role of emergency ureteroscopy in the management of ureteric stones: analysis of 394 cases. BJU Int. 2015;115(6):946-50.

55.  Zargar H, Zargar-Shoshtari K, Lotan Y, Shah JB, van Rhijn BW, Daneshmand S, et al. Final Pathological Stage after Neoadjuvant Chemotherapy and Radical Cystectomy for Bladder Cancer-Does pT0 Predict Better Survival than pTa/Tis/T1? J Urol. 2015.

56.  Zargar H, Zargar-Shoshtari K, Laydner H, Autorino R. Anatomy of Contemporary Partial Nephrectomy: A Dissection of the Available Evidence. Eur Urol. 2015;68(6):993-5.

57.  Sharma P, Zargar-Shoshtari K, Spiess PE. Current surgical management of penile cancer. Curr Probl Cancer. 2015;39(3):147-57.

58.  Sharma P, Zargar-Shoshtari K, Sexton WJ. Valrubicin in refractory non-muscle invasive bladder cancer. Expert Rev Anticancer Ther. 2015;15(12):1379-87.

59.  Sharma P, Zargar-Shoshtari K, Pow-Sang JM. Biomarkers for prostate cancer: present challenges and future opportunities. Future Science OA. 2015, Dec 17;2(1):FSO72.

60.  Sharma P, Zargar-Shoshtari K, Caracciolo JT, Richard GJ, Poch MA, Pow-Sang J, et al. Sarcopenia as a predictor of complications in penile cancer patients undergoing inguinal lymph node dissection. World J Urol. 2015;33(10):1585-92.

61.  Sharma P, Zargar-Shoshtari K, Caracciolo JT, Fishman M, Poch MA, Pow-Sang J, et al. Sarcopenia as a predictor of overall survival after cytoreductive nephrectomy for metastatic renal cell carcinoma. Urol Oncol. 2015;33(8):339 e17-23.

62.  Sharma P, Sverrisson EF, Zargar-Shoshtari K, Fishman MN, Sexton WJ, Dickinson SI, et al. Minimally invasive post-chemotherapy retroperitoneal lymph node dissection for nonseminoma. Can J Urol. 2015;22(4):7882-9.

63.  Sharma P, Fisher JS, Zargar-Shoshtari K, Gilbert SM, Pow-Sang JM, Sexton WJ, et al. Clinical utilization patterns of alvimopan in a contemporary cohort of patients undergoing radical cystectomy. Bladder. 2015;2(1):e11.

64.  Sharma P, Djajadiningrat R, Zargar-Shoshtari K, Catanzaro M, Zhu Y, Nicolai N, et al. Adjuvant chemotherapy is associated with improved overall survival in pelvic node-positive penile cancer after lymph node dissection: a multi-institutional study. Urol Oncol. 2015;33(11):496 e17-23.

65.  Sharma P, Dhillon J, Agarwal G, Zargar-Shoshtari K, Sexton WJ. Disparities in Interpretation of Primary Testicular Germ Cell Tumor Pathology. Am J Clin Pathol. 2015;144(2):289-94.

66.  Zargar-Shoshtari K, Kim T, Dhillon J, Lin HY, Yue B, Fishman M, et al. Using percentage of sarcomatoid differentiation as a prognostic factor in renal cell carcinoma. Clin Genitourin Cancer. 2015;13(3):225-30.

67.  Singh PP, Srinivasa S, Bambarawana S, Lemanu DP, Kahokehr AA, Zargar-Shoshtari K, et al. Perioperative use of statins in elective colectomy. Dis Colon Rectum. 2012;55(2):205-10.

68.  Sammour T, Kahokehr A, Zargar-Shoshtari K, Hill AG. A prospective case-control study of the local and systemic cytokine response after laparoscopic versus open colonic surgery. J Surg Res. 2012;173(2):278-85.

69.  Lemanu D, Srinivasa S, Singh P, Kahokehr A, Zargar-Shoshtari K, Hill AG. Propensity score analysis evaluating preoperative glucocorticoid administration in elective colectomy. Int J Surg. 2012;10(10):607-10.

70.  Paddison JS, Sammour T, Kahokehr A, Zargar-Shoshtari K, Hill AG. Development and validation of the Surgical Recovery Scale (SRS). J Surg Res. 2011;167(2):e85-91.

71.  Kahokehr AA, Zargar-Shoshtari K, Sammour T, Srinivasa S, Hill AG. Fatigue postopératoire: mythe ou réalité. Le Praticien en anesthésie réanimation. 2011;15(1):35-9.

72.  Kahokehr AA, Sammour T, Sahakian V, Zargar-Shoshtari K, Hill AG. Influences on length of stay in an enhanced recovery programme after colonic surgery. Colorectal Dis. 2011;13(5):594-9.

73.  Kahokehr A, Sammour T, Zargar Shoshtari K, Taylor M, Hill AG. Intraperitoneal local anesthetic improves recovery after colon resection: a double-blinded randomized controlled trial. Ann Surg. 2011;254(1):28-38.

74.  Sammour T, Zargar-Shoshtari K, Bhat A, Kahokehr A, Hill AG. A programme of Enhanced Recovery After Surgery (ERAS) is a cost-effective intervention in elective colonic surgery. N Z Med J. 2010;123(1319):61-70.

75.  Kahokehr A, Sammour T, Zargar-Shoshtari K, Srinivasa S, Hill AG. Recovery after open and laparoscopic right hemicolectomy: a comparison. J Surg Res. 2010;162(1):11-6.

76.  Zargar-Shoshtari K, Sammour T, Kahokehr A, Connolly AB, Hill AG. Randomized clinical trial of the effect of glucocorticoids on peritoneal inflammation and postoperative recovery after colectomy. Br J Surg. 2009;96(11):1253-61.

77.  Zargar-Shoshtari K, Paddison JS, Booth RJ, Hill AG. A prospective study on the influence of a fast-track program on postoperative fatigue and functional recovery after major colonic surgery. J Surg Res. 2009;154(2):330-5.

78.  Zargar-Shoshtari K, Hill AG. Postoperative fatigue: a review. World J Surg. 2009;33(4):738-45.

79.  Zargar Shoshtari K, Hill A. Authors reply Re: Fast-Track Surgery May Reduce Complications Following Major Colonic Surgery Reply. Dis Colon Rectum. 2009;52(10):1804-5.

80.  Vather R, Sammour T, Zargar-Shoshtari K, Metcalf P, Connolly A, Hill A. Lymph node examination as a predictor of long-term outcome in Dukes B colon cancer. Int J Colorectal Dis. 2009;24(3):283-8.

81.  Kahokehr A, Sammour T, Zargar-Shoshtari K, Thompson L, Hill AG. Implementation of ERAS and how to overcome the barriers. Int J Surg. 2009;7(1):16-9.

82.  Zargar-Shoshtari K, Short H, Poole GH, Hill AG. Acute laparoscopic cholecystectomy: preferred treatment for acute biliary disease. ANZ J Surg. 2008;78(9):771-4.

83.  Zargar-Shoshtari K, Hill AG. Fast-track open colectomy is possible in a New Zealand public hospital. N Z Med J. 2008;121(1275):33-6.

84.  Zargar-Shoshtari K, Hill AG. Optimization of perioperative care for colonic surgery: a review of the evidence. ANZ J Surg. 2008;78(1-2):13-23.

85.  Zargar-Shoshtari K, Connolly AB, Israel LH, Hill AG. Fast-track surgery may reduce complications following major colonic surgery. Dis Colon Rectum. 2008;51(11):1633-40.

86.  Vather R, Zargar-Shoshtari K, Metcalf P, Hill AG. The influence of hospital environment on postoperative length of stay following major colorectal surgery. N Z Med J. 2007;120(1266):U2828.

87.   Vather R, Zargar-Shoshtari K, Adegbola S, Hill AG. Comparison of the possum, P-POSSUM and Cr-POSSUM scoring systems as predictors of postoperative mortality in patients undergoing major colorectal surgery. ANZ J Surg. 2006;76(9):812-6.

88.  Vather R, Shoshtari KZ, Ducat C, Hill AG. Towards a 3-day hospital stay for right hemicolectomy. N Z Med J. 2006;119(1228):U1826.

89.  Shahrokh H, Rasouli H, Zargar MA, Karimi K, Zargar K. Spontaneous kidney allograft rupture. Transplant Proc. 2005;37(7):3079-80.

90.  Zargar MA, Emami M, Zargar K, Jamshidi M. The results of grade IV cystocele repair using mesh. Urol J. 2004;1(4):263-7.

91.   Zargar M, Mirzazadeh M, Zargar K. The appendix, an acceptable substitute for all segments of both ureters: a report of two cases. Medical Journal of The Islamic Republic of Iran (MJIRI). 2004;18(2):177-80.